<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01068171</url>
  </required_header>
  <id_info>
    <org_study_id>HSC-GEN-09-0418</org_study_id>
    <nct_id>NCT01068171</nct_id>
  </id_info>
  <brief_title>Developing a Diabetic Foot Ulcer Protocol</brief_title>
  <official_title>Developing a Diabetic Foot Ulcer Protocol in a Multi-ethnic, Underserved Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Harris County Hospital District</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Baylor College of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine which treatment, over 6 months, will promote
      healing of diabetic foot ulcers that are not infected in the most efficient, cost-effective
      way.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This pilot study will be conducted in Harris County Hospital District (HCHD) Community Health
      Centers and Wound Care Clinics.

      The study will use random assignment of patients who meet inclusion criteria to:
      postoperative shoe with or without collagen; removable Air-boot with or without collagen; or
      monitored Air-boot with or without collagen. All treatment is standard of care.

      Enrollment will occur at a clinic appointment. During the consent appointment, follow-up will
      be scheduled. Patients whose wound meets study criteria will be approached by a Podiatrist or
      therapist during a wound care visit. An A1c will be obtained, if not done within the past 3
      months. A convenience sample will be drawn from people with diabetes, aged 18 or more, who
      meet inclusion criteria.

      Frequency of visits will be:

        -  patients with monitored Air-boot: weekly

        -  all others: every 2 weeks At each visit there will be a dressing change, wound
           assessment and review of how many times shoe/boot was removed or not used during the
           preceding 1 or 2 weeks.

      Should healing not occur within 6 months or the wound progress, the patient will be referred
      for evaluation of possible vascular involvement.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2010</start_date>
  <completion_date type="Anticipated">December 2011</completion_date>
  <primary_completion_date type="Anticipated">December 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>decrease in size of wound</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>non-healing wound</measure>
    <time_frame>6 months or less</time_frame>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Diabetic Foot Ulcers</condition>
  <arm_group>
    <arm_group_label>shoe, plain dressing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>post-op shoe with plain occlusive dressing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>shoe, collagen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>post-op shoe with collagen dressing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>boot, plain dressing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>air boot with occlusive dressing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>boot, collagen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>air boot with collagen dressing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>monitored air boot, plain dressing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>air boot with retention strap to monitor whether boot is removed with occlusive dressing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>monitored boot with collagen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>air boot with retention strap to monitor whether boot is removed with collagen dressing</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>type of footwear</intervention_name>
    <description>comparison of results between post-op shoe, air boot which the patient can remove ad lib and air boot whose removal can be monitored</description>
    <arm_group_label>shoe, plain dressing</arm_group_label>
    <arm_group_label>boot, plain dressing</arm_group_label>
    <arm_group_label>monitored air boot, plain dressing</arm_group_label>
    <other_name>DJO XP Diabetic Walker</other_name>
    <other_name>Camcon Medical postoperative shoe</other_name>
    <other_name>Smith and Nephew Allevyn Foam dressing</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>collagen dressing with and without silver</intervention_name>
    <description>silver-impregnated collagen dressing will be used for 2 weeks, then plain collagen dressing will be used for the remainder of the 6 months</description>
    <arm_group_label>shoe, collagen</arm_group_label>
    <arm_group_label>boot, collagen</arm_group_label>
    <arm_group_label>monitored boot with collagen</arm_group_label>
    <other_name>Smith &amp; Nephew Biostep dressing with Allevyn Foam cover</other_name>
    <other_name>Smith &amp; Nephew Biostep Ag gressing with Allevyn Foam cover</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult - over 18 years of age

          -  Diabetes with an A1c of less than or equal to 9% - if no A1c result is available
             within the past 3 months, one will be drawn to qualify the patient for the study

          -  No evidence of circulatory compromise

               -  Posterior tibial or pedal pulse present on palpation

               -  No pallor on elevation

               -  No dependent rubor

          -  Loss of sensation on forefoot using monofilament

          -  Wound or callus on only 1 foot

          -  Wound Classification - Wagner Grade 1, non-infected

               -  Ulcer present for 1 - 3 months

               -  Ulcer of forefoot only

               -  No previous ulcer of that foot or amputation of either extremity

               -  Wound size &lt; 1&quot; diameter

               -  Wound bed pink

        Exclusion Criteria:

          -  Diagnoses with unpredictable trajectory or healing ability, i.e.

               -  Psychiatric disorders

               -  Cancer

               -  ESRD not eligible for dialysis

               -  HIV

          -  Previous lower extremity amputation

          -  Charcot foot

          -  Evidence of circulatory compromise

               -  Absence of pulses

               -  Decreased capillary refill (&gt; 3 seconds)

               -  Trophic skin changes - shiny, hairless toes

               -  Ankle Brachial Index &lt; 0.8
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gary Lepow, DPM</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Texas Health Science at Houston, Baylor College of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Talar L Glover, MS, RN, CNS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Harris County Hospital District</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Talar L Glover, MS, RN, CNS</last_name>
    <phone>713-566-2513</phone>
    <email>talar_glover@hchd.tmc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gary Lepow, DPM</last_name>
    <phone>713-790-0530</phone>
    <email>docgml@aol.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Harris County Hospital District Community Health</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77054</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Talar L Glover, MS, RN, CNS</last_name>
      <phone>713-566-2513</phone>
      <email>talar_glover@hchd.tmc.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 11, 2010</study_first_submitted>
  <study_first_submitted_qc>February 11, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 12, 2010</study_first_posted>
  <last_update_submitted>December 3, 2010</last_update_submitted>
  <last_update_submitted_qc>December 3, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 6, 2010</last_update_posted>
  <responsible_party>
    <name_title>Gary Lepow - Chief of Podiatry</name_title>
    <organization>UT Health Science Center - Houston and Baylor College of Medicine</organization>
  </responsible_party>
  <keyword>diabetes</keyword>
  <keyword>foot ulcers</keyword>
  <keyword>off-loading</keyword>
  <keyword>collagen</keyword>
  <keyword>Wagner 1</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Diabetic Foot</mesh_term>
    <mesh_term>Foot Ulcer</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

